-
Hims & Hers Health's Model 'Proving Effective': 2 Analysts Examine Q1 Earnings
Tuesday, May 7, 2024 - 12:57pm | 420Shares of Hims & Hers Health Inc (NYSE:HIMS) were climbing in early trading on Tuesday. The personal-care products company reported upbeat results for the first quarter. The results be reported amid an exciting earnings season. Here are some key analyst expectations. Piper Sandler analyst...
-
Teladoc Health Delivers Mixed Results, 'Sobering' Guidance: 6 Analysts Provide Key Takeaways
Wednesday, February 21, 2024 - 1:44pm | 704Shares of Teladoc Health Inc (NYSE: TDOC) tanked in early trading on Wednesday, after the company misses revenue expectations for the fourth quarter and issued weak first-quarter guidance. The results came amid an exciting earnings season. Here are some key analyst takeaways from the release. RBC...
-
7 Reasons Why This Teladoc Health Analyst Is Turning Bullish
Monday, August 17, 2020 - 1:59pm | 380Teladoc Health Inc’s (NYSE: TDOC) pro-forma revenue growth and synergy targets appear achievable, according to Credit Suisse. The Teladoc Health Analyst: Jailendra Singh upgraded Teladoc Health from Neutral to Outperform with a price target lifted from $225 to $249. The...